Next Article in Journal
Essential Oil Composition of Artemisia herba-alba from Southern Tunisia
Previous Article in Journal
Temozolomide with Radiation Therapy in High Grade Brain Gliomas: Pharmaceuticals Considerations and Efficacy;A Review Article
Molecules 2009, 14(4), 1578-1584; doi:10.3390/molecules14041578
Article

Trinor-cycloartane Glycosides from the Rhizomes of Cimicifuga foetida

1, 2, 1, 1, 2, 1, 2 and 1,*
1 State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, the Chinese Academy of Sciences, Kunming, 650204, P. R. China 2 Graduate School of Chinese Academy of Sciences, Beijing 100039, P. R. China
* Author to whom correspondence should be addressed.
Received: 16 March 2009 / Revised: 2 April 2009 / Accepted: 7 April 2009 / Published: 17 April 2009
View Full-Text   |   Download PDF [164 KB, uploaded 18 June 2014]   |  

Abstract

Three new trinor-cycloartane glycosides, 15α-hydroxy-16-dehydroxy-16(24)-en-foetidinol-3-O-β-D-xylopyranoside (1), 28-hydroxy-foetidinol-3-O-β-D-xylopyranoside (2) and foetidinol-3-O-β-D-xylopyranosyl-(1”→3’)-β-D-xylopyranoside (3) together with the known compound foetidinol-3-O-β-D-xylopyranoside (4) were isolated from the n-BuOH fraction of the roots of Cimicifuga foetida. Their structures were elucidated on the basis of spectroscopic and chemical reaction data.
Keywords: Cimicifuga foetida; Triterpenoids; Trinor-cycloartane; Glycosides Cimicifuga foetida; Triterpenoids; Trinor-cycloartane; Glycosides
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
SciFeed

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
RIS
MDPI and ACS Style

Lu, L.; Chen, J.; Nian, Y.; Sun, Y.; Qiu, M. Trinor-cycloartane Glycosides from the Rhizomes of Cimicifuga foetida. Molecules 2009, 14, 1578-1584.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert